IDCR, a forum for correctional problem solving,
targets correctional administrators and HIV/AIDS and hepatitis care
providers including physicians, nurses, outreach workers, and case
managers. Continuing Medical Education credits are provided by Medical Education Collaborative to physicians who accurately respond to the questions on the last page of the newsletter.
The
editorial board and contributors to IDCR include national and regional
correctional professionals, selected on the basis of their experience
with HIV and hepatitis care in the correctional setting and their
familiarity with current HIV and hepatitis treatment. We encourage
submissions, feedback, and correspondence from our readership.
ABOUT THIS CONTINUING EDUCATION ACTIVITY
This activity jointly sponsored by Medical Education Collaborative
and IDCR. Medical Education Collaborative is a non-profit organization
that delivers independent accreditation services and continuing
education expertise that improve healthcare education and professional
performance.
This activity is available via the medium of print and via the medium of online. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for
continuing Medical Education through the joint sponsorship of Medical
Education Collaborative, Inc. (MEC) and IDCR. MEC is accredited by the
ACCME to provide continuing medical education for physicians.
Medical Education Collaborative designates this educational activity
for a maximum of 1 AMA PRA Category 1 Credit(s)T. Physicians should
only claim credit commensurate with the extent of their participation
in the activity. Statements of credit will be mailed within 6 to 8
weeks following the program.
To obtain credit click on the above Content link, read the Main article and then click on the sidebar and read the Spotlight I, Spotlight II and News and Literature Reviews sections. When completed with all 4 items download the PDF version ( click here to download free adobe reader) of the monograph located on the sidebar and complete the post test, credit application and evaluation form at the end of the monograph. You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. To receive your certificate mail or fax the post test, credit application and evaluation to:
Medical Education Collaborative
651 Corporate Circle, Suite 104, Golden CO 80401
Phone: 303-420-3252
FAX: 303-420-3259
The material presented in this activity does not reflect the views of Medical Education Collaborative and IDCR. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. Medical Education Collaborative and IDCR do not recommend the use of any product outside of the labeled indications. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.
Release Date: 9-1-07
End Date: 9-30-08
|
SUPPORTERS
IDCR is grateful for the support of the following companies through educational grants:
Major Support
> Roche Pharmaceuticals
|
OBJECTIVES
- The learner will be able to explain how and why the Texas Department of Corrections incorporated a serum marker of hepatic fibrosis into its HCV evaluation and treatment guidelines.
- The learner will be able to summarize elements of HCV treatment policies that could aid in the reduction of litigation from HCV-infected inmates.
- The learner will be able to describe the Metavir Scoring System and it’s implication for the treatment of HCV.
|
PURPOSE STATEMENT AND TARGET AUDIENCE
The purpose of this newsletter is to increase the knowledge of physicians in correctional systems on determining what tests to use to assist them in treating HCV patients and what to include in a rationale HCV policy to prevent legal problems.
|
DISCLOSURES
Faculty Disclosure
The employees of Medical Education Collaborative have no financial relationships to disclose.
In accordance with the Accreditation Council for Continuing Medical
Education Standards for Commercial Support, the faculty for this
activity have been asked to complete Conflict of Interest Disclosure
forms. |
|
Executive Editor
Anne S. De Groot, MD
Adjunct Associate Professor
Warren Alpert School of Medicine of Brown University
Nothing to Disclose
Editor in Chief
David Alain Wohl, MD
Associate Professor of Medicine
Division of Infectious Diseases
AIDS Clinical Research Unit
The University of North Carolina- Chapel Hill
Disclosures: Speaker: Abbott Laboraties, Gilead Sciences, Inc., Tibotec Therapeutics, Roche Pharmaceuticals, Merck & Co.,
Boehringer-Ingelheim, Bristol-Myers Sqibb.
Deputy Editor
Joseph Bick, MD
Chief Medical Officer, California Medical Facility
California Department of Corrections
Nothing to Disclose
Renee Ridzon, MD
Senior Program Officer
HIV, TB, Reproductive Health
Bill & Melinda Gates Foundation
Nothing to Disclose
|
|
Disclosures: Main Article
David Paar, MD
Director, Clinical Virolog
The University of Texas Medical Branch- Correctional Managed Care
Disclosures: Speaker's Bureau: Vircus, Tibotec Therapeutics, and Boehringer Ingelheim; Advisor: Tibotec Therapeutics
|
Disclosures: Spotlight I
Joseph E Paris, PhD, MD, FSCP, CCHP
Consultant
Disclosures: Nothing to disclose
|
For questions regarding the accreditation of this activity, please contact Medical Education Collaborative at (303)420-3252, inquire@meccme.org
|
